Related Experiment Video
Updated: May 19, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Rhabdomyosarcoma of the trachea: first reported case treated with proton beam therapy
R Exley1, J M Bernstein, B Brennan
1Department of Head and Neck Surgical Oncology, Christie Hospital, Manchester, UK.
The Journal of Laryngology and Otology
|August 16, 2012
Summary
This case study details a rare tracheal rhabdomyosarcoma in a child, highlighting the first use of proton beam therapy for this condition. Proton therapy may offer improved outcomes and reduced side effects for pediatric patients.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
Background:
- Rhabdomyosarcoma is a rare childhood malignancy.
- Tracheal rhabdomyosarcoma is exceptionally rare, with only three prior reported cases.
- Multimodality treatment is standard for pediatric sarcomas.
Observation:
- A 14-month-old female presented with acute biphasic stridor.
- Emergency endoscopic debulking revealed an embryonal rhabdomyosarcoma with anaplasia.
- The patient received surgery, chemotherapy, and proton beam therapy.
Findings:
- This is the first reported case of proton beam therapy used for tracheal rhabdomyosarcoma.
- Proton beam therapy offers a potential alternative to conventional radiotherapy.
- Benefits may include reduced irradiation of the spinal cord in pediatric patients.
Implications:
- Proton beam therapy represents a promising advancement in treating rare pediatric tracheal tumors.
- This case expands treatment options for embryonal rhabdomyosarcoma.
- Further research into proton therapy for pediatric sarcomas is warranted.
